Agilent Technologies to Present at Evercore ISI HealthCONx

On November 12, 2018 Agilent Technologies Inc. (NYSE: A) reported the following webcast for the investment community (Press release, Agilent, NOV 12, 2018, http://www.agilent.com/about/newsroom/presrel/2018/12nov-gp18060.html [SID1234531275]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

Evercore ISI HealthCONx
Boston Harbor Hotel, Boston, Massachusetts
Tuesday, November 27, 2018 at 2:00 p.m. ET
Mike McMullen, Agilent president and chief executive offic

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!